论著 · 临床研究

急性心肌梗死介入治疗并发症风险预测模型构建

  • 阮青青 ,
  • 苏树智 ,
  • 李延婷 ,
  • 任渊 ,
  • 戴勇 ,
  • 乔增勇
展开
  • 1.安徽理工大学第一临床医学院,淮南 232001
    2.合肥综合性国家科学中心大健康研究院职业医学与健康联合研究中心(安徽理工大学),淮南 232001
    3.安徽理工大学计算机科学与工程学院,淮南 232001
    4.上海交通大学医学院附属国际和平妇幼保健院妇科,上海 201404
    5.安徽理工大学医学院,淮南 232001
    6.上海市奉贤区中心医院心血管内科,上海 201499
乔增勇,主任医师,博士;电子信箱:Qiaozy666@sina.com

收稿日期: 2025-03-20

  录用日期: 2025-07-03

  网络出版日期: 2025-12-28

基金资助

安徽省高校自然科学基金(2022AH040113);安徽理工大学医学专项培育项目(YZ2023H2A007);安徽理工大学职业医学与健康联合研究中心研究基金(OMH-2023-05)

Intraoperative complications in percutaneous coronary intervention for acute myocardial infarction: development of a risk prediction model

  • RUAN Qingqing ,
  • SU Shuzhi ,
  • LI Yanting ,
  • REN Yuan ,
  • DAI Yong ,
  • QIAO Zengyong
Expand
  • 1.School of First Clinical Medicine, Anhui University of Science & Technology, Huainan 232001, China
    2.Joint Research Center for Occupational Medicine and Health of IHM, Anhui University of Science & Technology, Huainan 232001, China
    3.School of Computer Science and Engineering, Anhui University of Science & Technology, Huainan 232001, China
    4.Department of Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201404, China
    5.School of Medicine, Anhui University of Science & Technology, Huainan 232001, China
    6.Department of Cardiovascular Medicine, Shanghai Fengxian Central Hospital, Shanghai 201499, China
QIAO Zengyong, E-mail: Qiaozy666@sina.com.

Received date: 2025-03-20

  Accepted date: 2025-07-03

  Online published: 2025-12-28

Supported by

Natural Science Research Project of Universities in Anhui Province(2022AH040113);Medical Special Cultivation Project of Anhui University of Science and Technology(YZ2023H2A007);Research Fund of Joint Research Center of Occupational Medicine and Health, Anhui University of Science and Technology(OMH-2023-05)

摘要

目的·急性心肌梗死(acute myocardial infarction,AMI)患者在接受经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)时,可能会出现低血压、恶性心律失常等严重并发症,这些并发症会直接影响手术的成功率以及患者的预后。在当前的临床评估中,缺乏针对性的工具,而传统的评估工具又存在预测效能不足的局限性。本研究创新性地运用机器学习方法,旨在构建一个精准的术中并发症预测模型,以解决现有评分系统对非线性关系捕捉不足的问题,为术者提供一个风险预警工具。方法·研究纳入了2019年至2022年上海市奉贤区中心医院就诊的811例急诊PCI患者,并定义了53项候选变量。采用多阶段特征工程框架,包括单变量初筛、Spearman等级相关性验证(Spearman rank correlation analysis)以及SHAP稳定性优化(SHapley additive exPlanations stability optimization),最终通过极端梯度提升(eXtreme gradient boosting,XGBoost)算法构建了预测模型。主要终点为术中复合并发症,即低血压、恶性心律失常以及严重缓慢型心律失常。结果·模型筛选出了6项核心预测因子,分别是急诊左心室射血分数(left ventricular ejection fraction,LVEF)最低值、罪犯血管为右冠状动脉(culprit vessel in right coronary artery,CVRCA)、存在罪犯血管(culprit vessel presence,CVP)、罪犯血管为左前降支动脉(culprit vessel in left anterior descending artery,CVADA)、B型利钠肽(B-type natriuretic peptide,BNP)和心率(heart rate,HR)。XGBoost模型在训练集与验证集的曲线下面积(area under the curve,AUC)分别为0.88和0.84。结论·成功构建了基于XGBoost算法的AMI患者PCI术中并发症预测模型,其预测效能显著优于传统评分系统。该模型通过自动筛选关键临床特征,有效捕捉变量间的复杂交互作用,能够为术者提供个体化的风险评估,从而更好地指导临床决策,提高手术成功率和患者预后。

本文引用格式

阮青青 , 苏树智 , 李延婷 , 任渊 , 戴勇 , 乔增勇 . 急性心肌梗死介入治疗并发症风险预测模型构建[J]. 上海交通大学学报(医学版), 2025 , 45(12) : 1589 -1597 . DOI: 10.3969/j.issn.1674-8115.2025.12.004

Abstract

Objective ·Patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) are at risk of severe complications, such as hypotension and malignant arrhythmias, which directly affect procedural success and patient prognosis. Current clinical practice lacks targeted assessment tools, and traditional assessment tools have limitations in predictive efficacy. This study innovatively applies machine learning methods to construct a precise intraoperative complication prediction model, addressing the insufficient non-linear relationship capture in existing scoring systems and providing an early risk warning tool for surgeons. Methods ·The study included 811 emergency PCI patients who were treated at Shanghai Fengxian Central Hospital from 2019 to 2022, and defined 53 candidate variables. A multi-stage feature engineering framework was employed, including univariate screening, Spearman rank correlation analysis verification, and SHapley Additive exPlanations (SHAP)-based stability optimization. The prediction model was ultimately constructed using the eXtreme Gradient Boosting (XGBoost) algorithm.The primary endpoint was a composite of intraoperative complications, including hypotension, malignant arrhythmias, and severe bradyarrhythmias. Results ·The model identified six core predictive factors: lowest left ventricular ejection fraction (LVEF), culprit vessel in the right coronary artery (CVRCA), culprit vessel presence (CVP), culprit vessel in the left anterior descending artery (CVADA), B-type natriuretic peptide (BNP), and heart rate (HR). The XGBoost model achieved areas under the curve (AUCs) of 0.88 and 0.84 in the training and validation sets, respectively. Conclusion ·This study successfully constructed, for the first time, an intraoperative complication prediction model for AMI patients undergoing PCI based on the XGBoost algorithm. Its predictive performance significantly outperforms that of traditional scoring systems. By automatically selecting key clinical features and effectively capturing complex interactions between variables, the model provides individualized risk assessment for surgeons, thereby supporting clinical decision-making and potentially improving procedural success rates and patient prognosis.

参考文献

[1] WEIGHT N, MOLEDINA S, SANTOS VOLGMAN A, et al. Socioeconomic disparities in the management and outcomes of acute myocardial infarction[J]. Heart, 2024, 110(2): 122-131.
[2] KIM C J, PARK M W, KIM M C, et al. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial[J]. Lancet, 2021, 398(10308): 1305-1316.
[3] OZAKI Y, TOBE A, ONUMA Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024[J]. Cardiovasc Interv Ther, 2024, 39(4): 335-375.
[4] MEIMOUN P, ABDANI S, STRACCHI V, et al. Usefulness of noninvasive myocardial work to predict left ventricular recovery and acute complications after acute anterior myocardial infarction treated by percutaneous coronary intervention[J]. J Am Soc Echocardiogr, 2020, 33(10): 1180-1190.
[5] KANABAR K, SHARMA Y P, KRISHNAPPA D, et al. A study of the predictive role of multiple variables for the incidence of acute kidney injury and its outcomes in Indian patients with ST-elevation myocardial infarction and cardiogenic shock[J]. Egypt Heart J, 2024, 76(1): 123.
[6] DOLL J A, HIRA R S, KEARNEY K E, et al. Management of percutaneous coronary intervention complications: algorithms from the 2018 and 2019 Seattle percutaneous coronary intervention complications conference[J]. Circ Cardiovasc Interv, 2020, 13(6): e008962.
[7] VEREVKIN A, VON ASPERN K, LEONTYEV S, et al. Early and long-term outcomes in patients undergoing cardiac surgery following iatrogenic injuries during percutaneous coronary intervention[J]. J Am Heart Assoc, 2019, 8: e010940.
[8] AHMAD Y, PETRIE M C, JOLICOEUR E M, et al. PCI in patients with heart failure: current evidence, impact of complete revascularization, and contemporary techniques to improve outcomes[J]. J Soc Cardiovasc Angiogr Interv, 2022, 1(2): 100020.
[9] KIM S H, BEHNES M, MASHAYEKHI K, et al. Prognostic impact of percutaneous coronary intervention of chronic total occlusion in acute and periprocedural myocardial infarction[J]. J Clin Med, 2021, 10(2): 258.
[10] JAVAID A, ZGHYER F, KIM C, et al. Medicine 2032: the future of cardiovascular disease prevention with machine learning and digital health technology[J]. Am J Prev Cardiol, 2022, 12: 100379.
[11] STANOJKOVIC A, MRDOVIC I, TOSIC I, et al. Prognostic value of the RISK-PCI score in patients with non-ST-segment elevation acute myocardial infarction[J]. J Clin Med, 2025, 14(8): 2727.
[15] ANGARAN P, DORIAN P, HA A, et al. P2618Association of left ventricular ejection fraction with mortality and hospitalizations[J]. Eur Heart J, 2019, 40(Supplement_1): ehz748.0941.
[16] LERMAN B J, POPAT R A, ASSIMES T L, et al. Association of left ventricular ejection fraction and symptoms with mortality after elective noncardiac surgery among patients with heart failure[J]. Jama, 2019, 321(6): 572.
[17] 张杰, 令狐克强, 柏小川. 老年急性非ST段抬高型心肌梗死患者PCI后心力衰竭发生的影响因素[J]. 中国老年学杂志, 2022, 42(2): 260-263.
  ZHANG J, LINGHU K Q, BAI X C. Influencing factors of heart failure after PCI in elderly patients with acute non-ST-segment elevation myocardial infarction[J]. Chinese Journal of Gerontology, 2022, 42(2): 260-263.
[18] LIU Y P, SONG J J, WANG W Y, et al. Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease[J]. ESC Heart Fail, 2022, 9(5): 3461-3468.
[19] 张频, 熊金睿, 邹婷婷, 等. 急性心肌梗死经皮冠状动脉介入术后不良心血管事件影响因素分析[J]. 中国校医, 2022, 36(11): 833-837.
  ZHANG P, XIONG J R, ZOU T T, et al. Analysis of influencing factors of adverse cardiovascular events after percutaneous coronary intervention in acute myocardial infarction[J]. Chinese Journal of School Doctor, 2022, 36(11): 833-837.
[20] HU M J, LU Y, WAN S P, et al. Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction[J]. Int J Cardiol, 2022, 351: 1-7.
[21] MONIZZI G, DI LENARDA F, GALLINORO E, et al. Myocardial ischemia: differentiating between epicardial coronary artery atherosclerosis, microvascular dysfunction and vasospasm in the catheterization laboratory[J]. J Clin Med, 2024, 13(14): 4172.
[22] TOSHNIWAL S S, TOSHNIWAL S S, KUMAR S, et al. Aberrant right coronary artery from the left coronary sinus presenting with inferior wall myocardial infarction[J]. Int J Appl Basic Med Res, 2024, 14(3): 199-201.
[23] XIONG X, YE Q, PENG Y Q. Risk factors for electrical storms following percutaneous coronary intervention in patients with acute myocardial infarction: a meta-analysis[J]. Biomol Biomed, 2024, 24(5): 1077-1091.
[24] TARANTINI G, MIGLIORE F, CADEMARTIRI F, et al. Left anterior descending artery myocardial bridging[J]. J Am Coll Cardiol, 2016, 68(25): 2887-2899.
[25] MA Z, NING B, WU D, et al. Correlation between culprit vessel/tirofiban and reperfusion bradyarrhythmia in patients with ST-segment elevation myocardial infarction after emergency PCI[J]. Eur Rev Med Pharmacol Sci, 2021, 25(16): 5137-5144.
[26] BHAR-AMATO J, AUROJIT R, KASSOU S, et al. Sudden cardiac death in acute coronary occlusion: potential roles of sino atrial nodal artery and conus artery[J]. Eur Heart J, 2024, 45(Supplement_1): ehae666.1672.
[27] COLLET J P, THIELE H. The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2020, 41(37): 3495-3497.
[28] WLEKLIK M, LEE C S, LEWANDOWSKI ?, et al. Frailty determinants in heart failure: inflammatory markers, cognitive impairment and psychosocial interaction[J]. ESC Heart Fail, 2025, 12(3): 2010-2022.
[29] SHEN S H, YE J H, WU X Z, et al. Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction: a meta-analysis[J]. Heart Lung, 2021, 50(6): 863-869.
[30] RAFLA S, AYAD S W, SANHOURY M. Study of bradyarrhythmias in acute myocardial infarction[J]. Egypt J Crit Care Med, 2022, 9(2): 51-56.
[31] BRINZA C, FLORIA M, SCRIPCARIU D V, et al. Heart rate variability in acute myocardial infarction: results of the HeaRt-V-AMI single-center cohort study[J]. J Cardiovasc Dev Dis, 2024, 11(8): 254.
文章导航

/